$37.70
0.30 (+0.80%)
St. Jude Medical, Inc. (STJ)
CAPS Rating:
Develops, manufactures and distributes cardiovascular medical devices for the cardiac rhythm management, cardiac surgery, cardiology, and atrial fibrillation therapy areas and implantable neuromodulation devices for the management of chronic pain.
Recs
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiac surgery, cardiology, and atrial fibrillation therapy areas and implantable neuromodulation devices. Has four main perating segments
December-quarter sales were up 1.1 billion, 11% from last year, the Cardiac Rhythm Management segment recorded a 7% top-line gain. The Cardiovascular Business also recorded a 7% gain, and the Neuromodulation (which is fun to say, made me feel smart) was up 32%
The CRM is becoming much more crowed as the baby boomers start to get older (I should look into who makes depends) and St. Jude is well positioned to take advantage of this, also the Atrial Fibrillation and Neuromodulation (had to throw it in again) offer significant long-term growth opportunities